[1] 牛福勇,李福荣,等.胆管细胞癌组织JAG1基因及其蛋白表达水平与患者预后的关系.实用肝脏病杂志,2017,20:736-739.
[2] 张国柄,徐江海,等.联合CA19-9、CA125和CEA检测在AFP阴性的ICC鉴别诊断中的应用价值.实用肝脏病杂志,2017,20:740-743.
[3] 苏飞,王欣,陈双倩等.经肝动脉化疗栓塞术联合无水乙醇瘤内注射治疗原发性肝癌的Meta分析.中华实验外科杂志,2014,31:1553-1555.
[4] 唐啸.根治性切除术辅助肝动脉化疗栓塞治疗肝内胆管细胞癌的疗效和预后分析.临床肝胆病杂志,2015,31:236-239.
[5] 饶文,叶锐剑,林桂华等.含洛铂化疗方案经肝动脉化疗栓塞术治疗原发性肝癌的疗效及安全性.中国生化药物杂志,2017,37:280-281,284.
[6] 王庆,周华邦,胡和平,等.肝内胆管细胞癌的现代认识与发展.中华肝脏病杂志,2017,25:336-338.
[7] Hideki S, Mina K, Altan B,et al. Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma. Dig liver dis,2015,47:590-596. |
